Democrats in Disarray over Drug Pricing Reform in Infrastructure Bill
Democrats’ efforts to reform drug pricing in the $3.5 trillion infrastructure have increasingly fractured the party.
Punchbowl News reported Friday that House moderate Democrats have been strategizing with Sens. Joe Manchin (D-WV) and Kyrsten Sinema (D-AZ) as the lawmakers oppose various measures of the mammoth bill.
Sinema reportedly has discussed House Energy and Commerce Democrats’ efforts to oppose drug pricing reform, which failed in the committee this week.
Reps. Scott Peters (D-CA), Kathleen Rice (D-NY), and Kurt Schrader (D-OR) voted with Republicans to oppose a plan that would allow the Health and Human Services (HHS) Department to negotiate prescription drug prices for Medicare recipients. Democrats hope to use the savings from this reform to expand vision, dental, and hearing programs in Medicare. This is a significant priority for the leftist Democrats.